MA S848

Requires 340B drug program covered entities to file annual reports with the Center for Health Information and Analysis beginning April 1, 2026

Mandates reporting of drug acquisition costs, payments received from insurers, and prescription volumes broken down by payor type (Medicaid, Medicare, commercial, uninsured)

Requires disclosure of operating costs for patient discount programs, sliding fee scales for patients below 200% of federal poverty level, and charity care expenditures

Compels reporting on contract pharmacy arrangements including total number, out-of-state locations, prescriptions filled, and all payments to contract pharmacies and third-party administrators

Reports must be certified by a covered entity officer and published on a publicly accessible website by the Center for Health Information and Analysis